Case series of liver transplantation in ""Dr. Rafael Ángel Calderón Guardia Hospital""
DOI:
https://doi.org/10.51481/amc.v63i1.1149Keywords:
transplant, liver transplant, solid organ transplant, immunosuppression, liverAbstract
Objective: To analyze the outcomes, most frequent complications and characteristics of the patients enrolled in the Liver Transplant Program from the Hospital ""Dr. Rafael Ángel Calderón Guardia"".
Methods: This is a retrospective investigation that involves the revision of clinical records from the patients that received a liver transplant between the years 2009 and 2018 in the Hospital ""Dr. Rafael Ángel Calderón Guardia"". The following variables were considered: age, gender, nationality, city of residence, manifestations of the liver disease, reason for the liver transplant, clinical outcomes after transplant, comorbidities, medication received, important laboratory results and biopsies. The data analysis was performed with STATA, using a statistic significance threshold of a p < 0.05.
Results: The sample was composed of a total of 45 liver transplant surgeries and 44 patients who received a liver transplant between the years 2009 and 2018. The patients mostly came from the city of San José. The average age at the time of the surgery was 51 years. The most common liver disease that led to transplant was alcoholic cirrhosis, followed by NASH and cryptogenic cirrhosis. The most common complications of the liver disease documented prior to transplant where esophageal varices, gastrointestinal bleeding and hepatic-renal syndrome. 10 of the patients included in the study died, which corresponds to 22.7% of the sample.
Conclusions: The mortality observed in the liver transplant cases analyzed was 22.7%, most of the cases were taken to transplantation due to liver disease related to alcoholic cirrhosis, steatohepatitis and cryptogenic cirrhosis.
Downloads
References
Salvalaggio PR, Caicedo JC. De Albuquerque LC, et al. Liver transplantation in Latin America: the state-of-the-art and future trends. Transplantation. 2014;98:241-246.
Bryce CL, Chang CC, Angus DC, Arnold EM, Farrell M, Roberts MS. The effect of race, sex, and insurance status on time-to-listing decisions for liver transplantation. J Transplant. 2010;2010:1-13.
Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: Does sex matter? J Hepatol. 2015;62:946-955.
Leonard J. Heimbach JK, Malinchoc M, Watt K, Charlton M. The Impact of obesity on long-term outcomes in liver transplant recipients—results of the NIDDK Liver Transplant Database. Am J Transplant. 2008;8:667-672.
Kim WR, Lake J, Smith J, Skeans M, Schladt D, Harper A, et al. OPTN/SRTR 2013 annual data report: liver. Am J Transplant. 2015;15:S1-S28.
Beckmann S, Drent G, Ruppar T, De Geest S. Weight gain, overweight and obesity in solid organ transplantation— a study protocol for a systematic literature review. Syst Rev. 2015;4:1
Aguilar M, Liu B, Holt EW, Bhuket T, Wong RJ. Impact of obesity and diabetes on waitlist survival, probability of liver
transplantation and post-transplant survival among chronic hepatitis C virus patients. Liver Int. 2016;36:1167-1176.
Burra P. Burroughs A, Graziadei I, Pirenne J, Valdecasas JC, Muiesan P, et al. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64:433-485.
Roberts MS. Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transplant. 2004;10:886-897.
Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006;5:77-85.
Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-96.
Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3:83-92.
Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of gram-nefative bloodstream infection in solid organ transplant recipients. Am J Transplant. 2009;9:835-843.
Feltracco P, Barbieri S, Galligioni H, Michieletto E, Carollo C, Ori C, et al. Intensive care management of liver transplanted patients. World J Hepatol. 2011;3:61-71.
Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transplant. 2000;6:521-530.
Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg. 1999; 5:S30-S
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
